Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;4(4):280-282.
doi: 10.1016/j.bsheal.2022.06.003. Epub 2022 Jul 9.

Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks

Affiliations

Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks

Balwir Matharoo-Ball et al. Biosaf Health. 2022 Aug.

Expression of concern in

  • Editorial note to previously published articles.
    [No authors listed] [No authors listed] Biosaf Health. 2023 Oct 27;5(6):372. doi: 10.1016/j.bsheal.2023.10.004. eCollection 2023 Dec. Biosaf Health. 2023. PMID: 40197764 Free PMC article. No abstract available.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has highlighted the practice of infectious diseases biobanking, as well as existing challenges and opportunities. Thus, the future of infectious diseases biobanking in the post-pandemic era, shall not be an "entry-level version" of its counterpart in non-communicable diseases and large population cohorts, but incorporate the lessons learned. Biobanks constitute a critical research infrastructure supported by harmonized practices through the implementation of international standards, and perceived within the broader scope of healthcare's intersection with research. This perspective paper considers the barriers in biobanking and standardization of practices, as well as the emerging opportunities in the field.

Keywords: Biobank best practices; Biobank networks; Biobank standards; Biobanks; COVID-19.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Li Q., Guan X., Wu P., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 2020;382:1199–1207. doi: 10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    1. Henderson M.K., Kozlakidis Z., Fachiroh J., Wiafe Addai B., Xu X., Ezzat S., Wagner H., Marques M.M., Yadav B.K. The responses of biobanks to COVID-19. Biopreserv Biobank. 2020;18(6):483–491. doi: 10.1089/bio.2020.29074.mkh. - DOI - PMC - PubMed
    1. Medina P.B., Garcia D.L., Cheong I.H., Lin R.T.P., Kozlakidis Z. Construction and application of biobanks for infectious diseases: focus on SARS-CoV-2. Innov. Digital Health Diagnost. Biomarkers. 2022;2:40–47. doi: 10.36401/IDDB-21-06. - DOI
    1. Campbell L.D., Astrin J.J., DeSouza Y., The,, et al. revision of the ISBER Best Practices: Summary of changes and the editorial team’s development process. Biopreserv. Biobank. 2018;16:3–6. doi: 10.1089/bio.2018.0001. - DOI - PMC - PubMed
    1. Organization for Economic Co-operation and Development (OECD) OECD Publishing; Paris, France: 2006. Creation and governance of human genetic research databases. - DOI

LinkOut - more resources